KCKe-Wei Chen

Ke-Wei Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ke-Wei Chen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Chen

    Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, Changsha, P. R. China

    1 shared publication
  • Cui-Zhen Wang

    Key Laboratory of Multiple Organ Failure (Zhejiang University), Ministry of Education, Department of General Intensive Care Unit of the Second Affiliated Hospital (Zhejiang University), Zhejiang University School of Medicine, Hangzhou, P. R. China

    1 shared publication
  • Huisi Huang

    State Key Laboratory of Bioactive Molecules and Draggability Assessment, Pharmacy College, Jinan University, Guangzhou, P. R. China

    1 shared publication
  • Jian-Bo Wang

    Department of Microbiology and Key Laboratory of Multiple Organ Failure (Zhejiang University), Ministry of Education, Department of General Intensive Care Unit of the Second Affiliated Hospital and Institute of Pharmaceutical Biotechnology

    1 shared publication
  • Longwei Gao

    Key Laboratory of Multiple Organ Failure (Zhejiang University), Ministry of Education, Department of General Intensive Care Unit of the Second Affiliated Hospital (Zhejiang University), Zhejiang University School of Medicine, Hangzhou, P. R. China

    1 shared publication
  • Min Li

    Key Laboratory of Tea Science of Ministry of Education, College of Horticulture, Hunan Agricultural University, Changsha, P. R. China

    1 shared publication

Latest Publications

  • Open Access

    Creating highly active fluoroacetate dehalogenases via gate-based synergetic chain design

    by Cui-Zhen Wang, Huisi Huang, Zhihui Hu, Longwei Gao, Zhi-Qiao Lin, Ming Shi, Zhiyong Song, Min Li, Yueming Wang, Ke-Wei Chen, et al.

    Gate residues, acting in concert with distal dynamic networks, are emerging as critical yet underexploited regulators of enzymatic catalysis. Here we show that conformational dynamics analysis of fluoroacetate dehalogenase RPA1163 reveals a gate-based allosteric pair (K181-W185) that governs substrate access and reactivity. Network engineering of this pair yields a double mutant with high turnover number for α-fluorophenylpropionic acid (turnover number > 2 × 10⁵), establishing gate-centric allostery as a generalizable design principle. Structural and molecular dynamics analyses show that the activity enhancement arises from stabilization of catalytically competent open states through long-range coupling. Extension of this strategy to three additional dehalogenases confirms the universality of gate-based dynamic rewiring. Leveraging this framework, we establish a robust biocatalytic platform for stereoselective synthesis of α-fluoro and α-hydroxy carboxylic acids, achieving high productivity (turnover number > 3.7 × 10⁶) and enabling decagram-scale preparation of pharmaceutically relevant intermediates with high yield and enantioselectivity. Together, these findings establish gate-residue allostery as a powerful concept in protein engineering, bridging conformational dynamics with translational biocatalysis.


  • New Insights into the Cooperativity and Dynamics of Dimeric Enzymes

    by Ke-Wei Chen, Tian-Yu Sun, Yun-Dong Wu

    A survey of protein databases indicates that the majority of enzymes exist in oligomeric forms, with about half of those found in the UniProt database being homodimeric. Understanding why many enzymes are in their dimeric form is imperative. Recent developments in experimental and computational techniques have allowed for a deeper comprehension of the cooperative interactions between the subunits of dimeric enzymes. This review aims to succinctly summarize these recent advancements by providing an overview of experimental and theoretical methods, as well as an understanding of cooperativity in substrate binding and the molecular mechanisms of cooperative catalysis within homodimeric enzymes. Focus is set upon the beneficial effects of dimerization and cooperative catalysis. These advancements not only provide essential case studies and theoretical support for comprehending dimeric enzyme catalysis but also serve as a foundation for designing highly efficient catalysts, such as dimeric organic catalysts. Moreover, these developments have significant implications for drug design, as exemplified by Paxlovid, which was designed for the homodimeric main protease of SARS-CoV-2.